Enterobacterial common antigen mutants of Salmonella enterica serovar typhimurium establish a persistent infection and provide protection against subsequent lethal challenge

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 441-450

  Gilbreath, Jeremy J ^a   Dodds, Jennifer Colvocoresses ^a,c   Rick, Paul D ^a   Soloski, Mark J ^b   Merrell, D Scott ^a   Metcalf, Eleanor S ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; ENTEROBACTERIAL COMMON ANTIGEN; LIPOPOLYSACCHARIDE; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; MUTANT PROTEIN; PHOSPHOTRANSFERASE; UDP GLCNAC UNDECAPRENYL PHOSPHATE N ACETYLGLUCOSAMINYL 1 PHOSPHATE TRANSFERASE; UDP-GLCNAC-UNDECAPRENYL PHOSPHATE N-ACETYLGLUCOSAMINYL 1-PHOSPHATE TRANSFERASE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CARBOHYDRATE SYNTHESIS; CELL MOTILITY; CELL SURFACE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FEMALE; FLAGELLUM; IMMUNIZATION; LIVER; MOUSE; MUTANT; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SPLEEN; TYPHOID FEVER; WILD TYPE; ANIMAL; ANIMAL SALMONELLOSIS; C57BL MOUSE; GENE DELETION; GENETIC COMPLEMENTATION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MORTALITY; PATHOGENICITY; PATHOLOGY; SURVIVAL;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GENE DELETION; GENETIC COMPLEMENTATION TEST; LIVER; MICE; MICE, INBRED C57BL; MUTANT PROTEINS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SPLEEN; SURVIVAL ANALYSIS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS); VIRULENCE FACTORS;

EID: 84857066229     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05559-11     Document Type: Article

References (64)

1. Albertson TE, et al. 2003. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gramnegative sepsis. Crit. Care Med. 31:419-427.
2. Anderson KV. 2000. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12:13-19.
3. Bahrani-Mougeot FK, et al. 2002. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol. 45: 1079 -1093.
4. Bangtrakulnonth A, et al. 2004. Salmonella serovars from humans and other sources in Thailand, 1993-2002. Emerg. Infect. Dis. 10:131-136.
5. Banks KE, et al. 2008. The enterobacterial common antigen-like gene cluster of Haemophilus ducreyi contributes to virulence in humans. J. Infect. Dis. 197:1531-1536.
6. Barr K, Klena J, Rick PD. 1999. The modality of enterobacterial common antigen polysaccharide chain lengths is regulated by o349 of the wec gene cluster of Escherichia coli K-12. J. Bacteriol. 181:6564-6568.
7. Barua S, et al. 2002. Involvement of surface polysaccharides in the organic acid resistance of Shiga Toxin-producing Escherichia coli O157:H7. Mol. Microbiol. 43:629-640.
8. Beaty CD, Franklin TL, Uehara Y, Wilson CB. 1994. Lipopolysaccharideinduced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur. J. Immunol. 24: 1278-1284.
9. Buzby JC, Roberts T, Lin CJ, MacDonald JM. 1996. Bacterial foodborne disease: medical costs and productivity losses. U.S. Department of Agriculture, Washington, DC. http://hdl.handle.net/10113/34242.
10. Carsiotis M, Weinstein DL, Karch H, Holder IA, O'Brien AD. 1984. Flagella of Salmonella typhimurium are a virulence factor in infected C57BL/6J mice. Infect. Immun. 46:814-818.
11. Castelli ME, et al. 2008. Enterobacterial common antigen integrity is a checkpoint for flagellar biogenesis in Serratia marcescens. J. Bacteriol. 190: 213-220.
12. Centers for Disease Control and Prevention. 1994. Salmonella surveillance report-annual summary-1990. Centers for Disease Control and Prevention, Atlanta, GA.
13. Chatfield SN, Dorman CJ, Hayward C, Dougan G. 1991. Role of ompRdependent genes in Salmonella typhimurium virulence: mutants deficient in both ompC and ompF are attenuated in vivo. Infect. Immun. 59: 449-452.
14. Chaudhuri RR, et al. 2009. Comprehensive identification of Salmonella enterica serovar Typhimurium genes required for infection of BALB/c mice. PLoS Pathog. 5:e1000529.
15. Curtiss R III, Kelly SM. 1987. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:3035-3043.
16. Darwin KH, Miller VL. 1999. Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin. Microbiol. Rev. 12:405- 428.
17. Dorman CJ, Chatfield S, Higgins CF, Hayward C, Dougan G. 1989. Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo. Infect. Immun. 57:2136 -2140.
18. Erbel PJ, et al. 2003. Identification and biosynthesis of cyclic enterobacterial common antigen in Escherichia coli. J. Bacteriol. 185:1995-2004.
19. Erridge C, Bennett-Guerrero E, Poxton IR. 2002. Structure and function of lipopolysaccharides. Microbes Infect. 4:837- 851.
20. Fadl AA, et al. 2005. Attenuation of Salmonella enterica serovar Typhimurium by altering biological functions of murein lipoprotein and lipopolysaccharide. Infect. Immun. 73:8433- 8436.
21. Fang FC, et al. 1992. The alternative sigma factor katF (rpoS) regulates Salmonella virulence. Proc. Natl. Acad. Sci. U. S. A. 89:11978 -11982.
22. Freudenberg MA, et al. 2008. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 213:193-203.
23. Giannella RA, Formal SB, Dammin GJ, Collins H. 1973. Pathogenesis of salmonellosis: studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J. Clin. Invest. 52:441- 453.
24. Haraga A, Ohlson MB, Miller SI. 2008. Salmonellae interplay with host cells. Nat. Rev. Microbiol. 6:53- 66.
25. Heumann D, Roger T. 2002. Initial responses to endotoxins and Gramnegative bacteria. Clin. Chim Acta 323:59 -72.
26. Hoiseth SK, Stocker BA. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238 -239.
27. Ilg K, et al. 2009. O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice. Infect. Immun. 77:2568 -2575.
28. Jones BD, Ghori N, Falkow S. 1994. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J. Exp. Med. 180:15-23.
29. Kopp EB, Medzhitov R. 1999. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:13-18.
30. Kuhn HM, Meier-Dieter U, Mayer H. 1988. ECA, the enterobacterial common antigen. FEMS Microbiol. Rev. 4:195-222.
31. Lawlor MS, Hsu J, Rick PD, Miller VL. 2005. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol. Microbiol. 58:1054 -1073.
32. Lew HC, Nikaido H, Makela PH. 1978. Biosynthesis of uridine diphosphate N-acetylmannosaminuronic acid in rff mutants of Salmonella typhimurium. J. Bacteriol. 136:227-233.
33. Licht TR, et al. 1996. Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect. Immun. 64:3811-3817.
34. Lindgren SW, Stojiljkovic I, Heffron F. 1996. Macrophage killing is an essential virulence mechanism of Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 93:4197- 4201.
35. Loppnow H, Brade H, Rietschel ET, Flad HD. 1994. Induction of cytokines in mononuclear and vascular cells by endotoxin and other bacterial products. Methods Enzymol. 236:3-10.
36. Matsui H, et al. 2003. Oral immunization with ATP-dependent proteasedeficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium. Infect. Immun. 71: 30-39.
37. Mayer H, Schmidt G. 1979. Chemistry and biology of the enterobacterial common antigen (ECA). Curr. Top. Microbiol. Immunol. 85:99 -153.
38. Medzhitov R, Janeway C Jr. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173:89 -97.
39. Meier U, Mayer H. 1985. Genetic location of genes encoding enterobacterial common antigen. J. Bacteriol. 163:756 -762.
40. Miller SI, Kukral AM, Mekalanos JJ. 1989. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. U. S. A. 86:5054 -5058.
41. Monack DM, Bouley DM, Falkow S. 2004. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+mice and can be reactivated by IFNgamma neutralization. J. Exp. Med. 199:231-241.
42. Nelson DL, Kennedy EP. 1972. Transport of magnesium by a repressible and a nonrepressible system in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 69:1091-1093.
43. Nevola JJ, Stocker BA, Laux DC, Cohen PS. 1985. Colonization of the mouse intestine by an avirulent Salmonella typhimurium strain and its lipopolysaccharide-defective mutants. Infect. Immun. 50:152-159.
44. O'Brien AD, Taylor BA, Rosenstreich DL. 1984. Genetic control of natural resistance to Salmonella typhimurium in mice during the late phase of infection. J. Immunol. 133:3313-3318.
45. O'Callaghan D, Maskell D, Liew FY, Easmon CS, Dougan G. 1988. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423.
46. Ohl ME, Miller SI. 2001. Salmonella: a model for bacterial pathogenesis. Annu. Rev. Med. 52:259 -274.
47. Pegues DA, Hohmann EL, Miller SI. 1995. Salmonella, including S. typhi, p. 785-809. In Blaser MJ (ed.), Infections of the gastrointestinal tract. Raven Press, New York, NY.
48. Rabsch W, Tschape H, Baumler AJ. 2001. Non-typhoidal salmonellosis: emerging problems. Microbes Infect. 3:237-247.
49. Ramos-Morales F, Prieto AI, Beuzon CR, Holden DW, Casadesus J. 2003. Role for Salmonella enterica enterobacterial common antigen in bile resistance and virulence. J. Bacteriol. 185:5328 -5332.
50. Rick PD, Mayer H, Neumeyer BA, Wolski S, Bitter-Sueermann D. 1985. Biosynthesis of enterobacterial common antigen. J. Bacteriol. 162: 495-503.
51. Rick PD, et al. 1998. Characterization of the lipid-carrier involved in the synthesis of enterobacterial common antigen (ECA) and identification of a novel phosphoglyceride in a mutant of Salmonella typhimurium defective in ECA synthesis. Glycobiology 8:557-567.
52. Rick PD, et al. 1995. Enterobacterial common antigen and capsular polysaccharides, p. 104 -112. In Neidhardt FC, et al. (ed.), Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, DC.
53. Rietschel ET, et al. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217-225.
54. Rodriguez-Morales O, et al. 2006. Salmonella enterica serovar Typhimurium ompS1 and ompS2 mutants are attenuated for virulence in mice. Infect. Immun. 74:1398 -1402.
55. Rose RE. 1988. The nucleotide sequence of pACYC184. Nucleic Acids Res. 16:355.
56. Schletter J, Heine H, Ulmer AJ, Rietschel ET. 1995. Molecular mechanisms of endotoxin activity. Arch. Microbiol. 164:383-389.
57. Sydenham M, et al. 2000. Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines. Infect. Immun. 68:1109 -1115.
58. Tauxe RV. 1996. An update on Salmonella. Health Environ. Digest 10:1- 4.
59. Toguchi A, Siano M, Burkart M, Harshey RM. 2000. Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide. J. Bacteriol. 182:6308-6321.
60. Tsai CM, Frasch CE. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
61. Valtonen MV, Larinkari UM, Plosila M, Valtonen VV, Makela PH. 1976. Effect of the enterobacterial common antigen on mouse virulence of Salmonella typhimurium. Infect. Immun. 13:1601-1605.
62. Wray C, Sojka WJ. 1978. Experimental Salmonella typhimurium infection in calves. Res. Vet. Sci. 25:139 -143.
63. Yamamoto T, et al. 2001. Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha. Infect. Immun. 69:3164 -3174.
64. Zhang L, Radziejewska-Lebrecht J, Krajewska-Pietrasik D, Toivanen P, Skurnik M. 1997. Molecular and chemical characterization of the lipopolysaccharide O-antigen and its role in the virulence of Yersinia enterocolitica serotype O:8. Mol. Microbiol. 23:63-76.